跳至主要内容
临床试验/NCT07020000
NCT07020000尚未招募不适用

A Multi-Center Post-Marketing Data Collection Protocol to Evaluate the Safety, Performance, and Health Economics of the Endoscopic Assisted Retropsoas (EARP) Interbody System for Lumbar Interbody Fusion Surgery

Retropsoas Technologies, LLC3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年8月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
试验地点
3
主要终点
Radiographic measurements prior to surgery and at follow-up visits

研究概览

简要总结

The goal of the trial is to generate data to support the safety, performance, and cost effectiveness of using the EARP devices during Lumbar Interbody Fusion (LIF) procedures.

The primary objectives are:

  • To evaluate the safety of the EARP surgical technique and devices during LIF surgeries.
  • To understand the EARP fusion system's ability to achieve fusion and improve disk space over time.

详细描述

This multi-center post-marketing study will include consecutive patients who meet eligibility criteria, are scheduled to undergo a LIF procedure using the EARP Interbody System and EARP Nerve Cuff Electrode, and agree to participate. The study will include patients deemed appropriate for the procedure per the site's judgment, which may include patients with off-label use of the devices. Patients who consent to study participation and meet study criteria will undergo surgery according to site standard procedure. The EARP Nerve Cuff Electrode will be used to monitor nerve roots during surgery. Radiographic imaging will document the fusion status and various disk space parameters, and the Oswestry Disability Index (ODI) will be used to assess function and pain. Data will be collected from standard site follow-up visits at 6 weeks, 3 months, 6 months, and 12 months after surgery. Economic data will be collected to quantify the economics of the EARP Interbody System for LIF procedures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing LIF between L2-S1

排除标准

  • BMI >40 kg/m2
  • Pregnant or plans on becoming pregnant in the near future
  • Surgery requires combination of EARP with another lumbar interbody fusion technique (PLIF, TLIF, ALIF, OLIF, LLIF) or posterolateral fusion at another level
  • History of lumbar interbody pseudoarthrosis at planned operative level
  • Lumbar spondylolisthesis ≥ grade 3
  • Osteoporotic vertebral compression fracture treated or untreated at planned operative site
  • History of lumbar spinal metastasis
  • Acute lumbar spine trauma requiring immediate intervention
  • Owestry Disability Index (ODI) 81-100%
  • Presence of personality disorder or major psychiatric illness
  • History of allergy to titanium, platinum, PEEK, aluminum, stainless steel or silicone
  • Any additional factor that makes the patient an unsuitable candidate for the study in the opinion of the principal investigator

结局指标

主要结局

Radiographic measurements prior to surgery and at follow-up visits

时间窗: From enrollment until the end of follow-up at 12 months

Radiographic measurements including X-Ray, CT Scans, and MRIs if available

To evaluate the safety of the EARP surgical technique and devices used during LIF surgeries

时间窗: From surgery until the end of follow up at 12 months

Adverse Device Events and surgical complications due to the devices

次要结局

  • Assess the ability of the EARP fusion system to reduce pain and restore function(Baseline to final follow-up visit at 12 months)
  • Assess IONM data during procedure related to the effectiveness of the EARP Nerve Cuff Electrode(During Surgery)
  • Quantify health economic factors associated with the EARP fusion system for LIF procedures(From surgery to end of follow up at 12 months)

研究者

发起方
Retropsoas Technologies, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验